Top

Reactions Weekly

Published in:

01-07-2023 | Thrombotic Microangiopathy | Case report

Carfilzomib/lenalidomide

Lack of efficacy and thrombotic microangiopathy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Catanese L, et al. Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition. BMC Nephrology 24: 2023. Available from: URL: http://doi.org/10.1186/s12882-023-03228-9

Title: Carfilzomib/lenalidomide
Lack of efficacy and thrombotic microangiopathy: case report
Publication date: 01-07-2023
Publisher: Springer International Publishing
Keywords: Thrombotic Microangiopathy
Hyperkalemia
Metabolic Acidosis
Maintenance Therapy
Dexamethasone
Stem Cell Transplantation
Stem Cell Transplantion
Stem Cell Transplantation
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-43108-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Carfilzomib/lenalidomide

Lack of efficacy and thrombotic microangiopathy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Ipilimumab/nivolumab

Amphotericin-b-liposomal/fingolimod/flucytosine

Bevacizumab/carboplatin/doxorubicin

Tozinameran

Adalimumab

Levetiracetam